Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Mar 28 FBIO Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Mar 28 REGN Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Mar 28 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults
Mar 28 REGN Stock-Split Watch: Are These 2 Top Growth Stocks Next?
Mar 28 REGN Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
Mar 26 REGN Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
Mar 26 REGN Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Mar 26 REGN Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?
Mar 25 LXRX Lexicon Pharmaceuticals files to sell 57.66M shares for holders
Mar 25 RCUS Navigating 5 Analyst Ratings For Arcus Biosciences
Mar 25 REGN FDA declines to approve Regeneron lymphoma drug odronextamab
Mar 25 LXRX Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo
Mar 25 FBIO Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Mar 25 REGN FDA rejects Regeneron lymphoma drug, setting back company’s oncology push
Mar 25 REGN UPDATE 3-Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
Mar 25 REGN Regeneron Provides Update on Biologics License Application for Odronextamab
Mar 23 NBIX S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
Mar 22 REGN Intellia opts out of hemophilia pact with Regeneron
Mar 22 FBIO Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Mar 22 NBIX Dow Jones Futures: Apple Sour, But These 11 Stocks Flash Buy Signals; FedEx Soars Late
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags